Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma

Seminars in Reproductive Medicine

Volumn 28, Issue 3, 2010, Pages 250-259

  Yu, Linda ^a   Moore, Alicia B ^a   Dixon, Darlene ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Fibroids; Growth factors; Hormonal regulation; Leiomyoma; Receptor tyrosine kinases (RTKs); Uterus

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

HORMONAL REGULATION; HUMAN; IN VITRO STUDY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; UTERUS MYOMA;

ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HORMONES; HUMANS; LEIOMYOMA; MITOGEN-ACTIVATED PROTEIN KINASES; PROGESTERONE; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; UTERINE NEOPLASMS;

EID: 77951517877     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1251482     Document Type: Review

References (49)

1. Li E, Hristova K. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry 2006 45 (20) 6241-6251 (Pubitemid 43787791)
2. Bennasroune A, Gardin A, Aunis D, Crémel G, Hubert P. Tyrosine kinase receptors as attractive targets of cancer therapy. Crit Rev Oncol Hematol 2004 50 (1) 23-38 (Pubitemid 38501615)
3. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002 2 (10) 795-803 (Pubitemid 37328914)
4. Yu L, Saile K, Swartz C D. et al. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol Med 2008 14 (56) 264-275 (Pubitemid 351785699)
5. Wang J, Ohara N, Wang Z et al. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum Reprod 2006 21 (7) 1869-1877 (Pubitemid 44028263)
6. Flake G P., Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003 111 (8) 1037-1054 (Pubitemid 36826884)
7. Shushan A, Ben-Bassat H, Mishani E, Laufer N, Klein B Y., Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril 2007 87 (1) 127-135 (Pubitemid 46013862)
8. Mangrulkar R S., Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak R A. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod 1995 53 (3) 636-646
9. Wolaska M, Bakowski E. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth. Biochimie 2006 88 (2) 141-146
10. Liang M, Wang H, Zhang Y, Lu S, Wang Z. Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Biol Ther 2006 5 (1) 28-33 (Pubitemid 43234974)
11. Van der Ven L T., Roholl P J., Gloudemans T et al. Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. Br J Cancer 1997 75 (11) 1631-1640 (Pubitemid 27229054)
12. Crosier P S., Freeman S A., Orlic D, Bodine D M., Crosier K E. The Dtk receptor tyrosine kinase, which binds protein S, is expressed during hematopoiesis. Exp Hematol 1996 24 (2) 318-323 (Pubitemid 26093901)
13. Motoyoshi K. Function, molecular structure and gene expression of macrophage colony-stimulating factor [in Japanese]. Nippon Rinsho 1992 50 (8) 1861-1866
14. Ptzer B M., Drosten M. The RET proto-oncogene: a potential target for molecular cancer therapy. Trends Mol Med 2004 10 (7) 351-357 (Pubitemid 38881525)
15. Forrester W C. The Ror receptor tyrosine kinase family. Cell Mol Life Sci 2002 59 (1) 83-96 (Pubitemid 34117358)
16. Hoch W. Molecular dissection of neuromuscular junction formation. Trends Neurosci 2003 26 (7) 335-337 (Pubitemid 36794545)
17. Brantley-Sieders D M., Chen J. Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis 2004 7 (1) 17-28 (Pubitemid 39127767)
18. Sun W S., Fujimoto J, Tamaya T. Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma. Mol Hum Reprod 2003 9 (11) 701-707 (Pubitemid 37483957)
19. Schlessinger J, Lemmon M A. Nuclear signaling by receptor tyrosine kinases: the first robin of spring. Cell 2006 127 (1) 45-48 (Pubitemid 44466641)
20. McKay M M., Morrison D K. Integrating signals from RTKs to ERK/MAPK. Oncogene 2007 26 (22) 3113-3121
21. Barbarisi A, Petillo O, Di Lieto A et al. 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol 2001 186 (3) 414-424 (Pubitemid 32147725)
22. Levin E R. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005 19 (8) 1951-1959
23. Mesquita F S., Dyer S N., Heinrich D A. et al. Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod 2010 82 (2) 341-351
24. Orcy R B., Brum I, da Silva R S., Kucharski L C., Corleta H E., Capp E. Insulin receptor tyrosine kinase activity and substrate 1 (IRS-1) expression in human myometrium and leiomyoma. Eur J Obstet Gynecol Reprod Biol 2005 123 (1) 107-110 (Pubitemid 41563103)
25. Cook J D., Walker C L. Treatment strategies for uterine leiomyoma: the role of hormonal modulation. Semin Reprod Med 2004 22 (2) 105-111
26. Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 2002 78 (1) 1-12 (Pubitemid 34722662)
27. Buttram V C. Jr, Reiter R C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981 36 (4) 433-445
28. Dixon D, Flake G P., Moore A B. et al. Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch 2002 441 (1) 53-62 (Pubitemid 34754249)
29. Lannigan D A. Estrogen receptor phosphorylation. Steroids 2003 68 (1) 1-9
30. Bunone G, Briand P A., Miksicek R J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996 15 (9) 2174-2183 (Pubitemid 26141134)
31. Hermon T L., Moore A B., Yu L, Kissling G E., Castora F J., Dixon D. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Virchows Arch 2008 453 (6) 557-569
32. Shimomura Y, Matsuo H, Samoto T, Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 1998 83 (6) 2192-2198 (Pubitemid 28496358)
33. Yamada T, Nakago S, Kurachi O et al. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum Reprod 2004 19 (4) 815-821 (Pubitemid 38456044)
34. Swartz C D., Afshari C A., Yu L, Hall K E., Dixon D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 2005 11 (6) 441-450 (Pubitemid 41430098)
35. Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 2003 209 (1-2) 9-16 (Pubitemid 37353078)
36. Kato S, Endoh H, Masuhiro Y et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995 270 (5241) 1491-1494
37. Zhao Y, Zhang W, Wang S. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma. Gynecol Endocrinol 2008 24 (10) 549-554
38. Hassan M H., Salama S A., Arafa H M., Hamada F M., Al-Hendy A. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. J Clin Endocrinol Metab 2007 92 (10) 3949-3957 (Pubitemid 47607646)
39. Dixon D, He H, Haseman J K. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect 2000 108 (Suppl 5) 795-802
40. Di X, Yu L, Moore A B. et al. A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. Hum Reprod 2008 23 (8) 1873-1883 (Pubitemid 352019996)
41. van der Ven L T., Gloudemans T, Roholl P J. et al. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 1994 59 (3) 427-434 (Pubitemid 24331838)
42. Murphy L J., Ghahary A. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 1990 11 (3) 443-453 (Pubitemid 20261695)
43. Adesanya O O., Zhou J, Bondy C A. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J Clin Endocrinol Metab 1996 81 (5) 1967-1974 (Pubitemid 26152493)
44. Giudice L C., Irwin J C., Dsupin B A. et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 1993 8 (11) 1796-1806 (Pubitemid 23337135)
45. Newbold R R. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 2004 199 (2) 142-150
46. Newbold R R., Banks E P., Bullock B, Jefferson W N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001 61 (11) 4325-4328 (Pubitemid 32685752)
47. Hunter D S., Hodges L C., Eagon P K. et al. Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids. Environ Health Perspect 2000 108 (suppl 5) 829-834
48. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993 342 (8881) 1209-1210 (Pubitemid 23331713)
49. Wang T T., Sathyamoorthy N, Phang J M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996 17 (2) 271-275 (Pubitemid 26091305)